BNZI - Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
RxSight shares jumped 20% to $44.31 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash.
- Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion.
- Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96.
- Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update.
- Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22.
- Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193.
- NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32.
- Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio.
- QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563.
- Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3.
- Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51.
- Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024.
- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025.
- Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific.
- Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance.
- LendingTree, Inc. (NASDAQ: TREE) ...